These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20346215)

  • 1. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density.
    Yang DX; Li NE; Ma Y; Han YC; Shi Y
    Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of Elf-1 and vascular endothelial growth factor in non-small cell lung cancer].
    Yang DX; Han YC; Liu LY; Yu N; Wang X; Shi Y
    Ai Zheng; 2009 Jul; 28(7):762-7. PubMed ID: 19624906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
    Wang L; Li X; Li Y; Xue YW
    Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcellular localization of survivin in non-small cell lung cancer].
    He L; Hou M; Zhang J; Xu N; Chen P
    Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
    Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
    Gao Q; Yang S; Kang MQ
    Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
    Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
    Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
    Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of survivin and its clinical significance in non-small cell lung cancer].
    Ren YJ; Zhang QY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):504-7. PubMed ID: 16224523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
    Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
    Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
    BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.